View Older Stories View More Recent Stories

Mar 10, 2026 09:29AM William Blair Reiterates Outperform Rating on LENZ Therapeutics Inc (LENZ): "continue to believe VIZZ holds blockbuster potential"
Mar 10, 2026 09:00AM Truelink Capital Closes Oversubscribed Fund II at $2.0 Billion Hard Cap
Mar 10, 2026 08:29AM William Blair Reiterates Outperform Rating on Standex International (SXI) following meetings with management
Mar 10, 2026 06:34AM William Blair Starts BridgeBio Pharma (BBIO) at Outperform
Mar 10, 2026 05:06AM Analysis-Gabon's uncertain push for IMF loan leads regional return to Fund
Mar 9, 2026 05:00PM MiniMed closes IPO raising $538 million at $20 per share
Mar 9, 2026 04:59PM MiniMed announces closing of Initial Public Offering
Mar 9, 2026 04:57PM William Blair Reiterates Outperform Rating on Nayax (NYAX) following earnings
Mar 9, 2026 04:19PM William Blair Reiterates Outperform Rating on StoneX Group Inc. (SNEX): "current price looks highly attractive"
Mar 9, 2026 04:01PM Dianthus Therapeutics announces $400 million public stock offering
Mar 9, 2026 04:01PM Xenon Pharmaceuticals announces $500 million public offering
Mar 9, 2026 04:01PM Xenon Pharmaceuticals Announces Proposed Public Offering
Mar 9, 2026 04:01PM Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
Mar 9, 2026 03:12PM William Blair Reiterates Outperform Rating on Kalaris (KLRS): "we see blockbuster potential for TH103 in nAMD"
Mar 9, 2026 02:44PM William Blair Reiterates Outperform Rating on Microsoft (MSFT) following product announcements
Mar 9, 2026 02:37PM William Blair Reiterates Market Perform Rating on ULTA Beauty (ULTA) ahead of earnings
Mar 9, 2026 02:30PM William Blair: 'We expect Microsoft to continue expanding its enterprise wallet share'
Mar 9, 2026 01:14PM William Blair Reiterates Outperform Rating on Crawford & Company (CRD-B): "Significant upside is possible"
Mar 9, 2026 11:52AM William Blair Reiterates Outperform Rating on Abbvie (ABBV): "competitive across the amylin class"
Mar 9, 2026 09:00AM William Blair Downgrades TalkSpace (TALK) to Market Perform
Mar 9, 2026 08:26AM William Blair Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE): "we see further room for upside"
Mar 9, 2026 08:15AM William Blair Reiterates Outperform Rating on Korn/Ferry (KFY) following Q3 results
Mar 9, 2026 08:11AM William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): "remain bullish here"
Mar 9, 2026 08:01AM William Blair Reiterates Outperform Rating on ARS Pharmaceuticals Inc (SPRY) following Q4 results
Mar 9, 2026 07:41AM William Blair: '$15 move in oil can cause FCF yield to more than double'
Mar 9, 2026 07:30AM Korro Bio raises $85 million in oversubscribed private placement
Mar 9, 2026 07:30AM Korro Announces Oversubscribed $85 Million Private Placement
Mar 9, 2026 06:10AM William Blair Starts Jade Biosciences (JBIO) at Outperform
Mar 6, 2026 03:33PM William Blair Reiterates Outperform Rating on Amprius Technologies (AMPX): "best-positioned arms dealer to supply this burgeoning industry"
Mar 6, 2026 03:32PM William Blair Reiterates Outperform Rating on Stitch Fix, Inc. (SFIX): "Pullback Creates Compelling Entry Point"
Mar 6, 2026 12:30PM Holding(s) in Company
Mar 6, 2026 09:03AM William Blair Reiterates Outperform Rating on Crescent Energy (CRGY) following convertible notes offering announcement
Mar 6, 2026 07:06AM William Blair Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Market Perform, Removed from Analyst Conviction List
Mar 6, 2026 06:28AM William Blair: 'we believe Marvell is well positioned to grab its fair share of the AI infrastructure wallet'
Mar 6, 2026 05:11AM SCHMID Group N.V. announces closing of the second tranche of its USD 30 million convertible notes financing
Mar 6, 2026 01:49AM Ingram Micro prices secondary offering at $22.25 per share
Mar 6, 2026 01:49AM Ingram Micro Holding Corporation Announces Pricing of Secondary Offering of Common Stock by its Principal Stockholder.
Mar 5, 2026 07:34PM MiniMed prices IPO at $20 per share, raising $560 million
Mar 5, 2026 07:33PM MiniMed announces pricing of initial public offering
Mar 5, 2026 05:05PM Form 497K WILLIAM BLAIR FUNDS
Mar 5, 2026 05:04PM Form 485BPOS WILLIAM BLAIR FUNDS
Mar 5, 2026 04:27PM William Blair Reiterates Outperform Rating on BJ's Wholesale (BJ), but "we expect BJ’s will deliver first-quarter comps below 2%"
Mar 5, 2026 02:08PM William Blair Reiterates Market Perform Rating on WillScot Holdings Corp (WSC): "we expect project activity to remain depressed"
Mar 5, 2026 01:02PM William Blair Reiterates Market Perform Rating on Zillow (Z) following stock buyback announcements
Mar 5, 2026 12:38PM Analysis-Down but not out: Emerging markets could endure Middle East shocks, investors say
Mar 5, 2026 11:55AM William Blair Reiterates Outperform Rating on Sight Sciences Inc. (SGHT) following earnings call
Mar 5, 2026 11:39AM William Blair Reiterates Outperform Rating on Monolithic Power Systems (MPWR)
Mar 5, 2026 11:37AM William Blair Reiterates Outperform Rating on Compass Therapeutics (CMPX)
Mar 5, 2026 11:35AM William Blair Reiterates Outperform Rating on USA Rare Earth Inc (USAR): "We believe shares could trade at a 10x multiple"
Mar 5, 2026 11:31AM William Blair Reiterates Market Perform Rating on Altimmune (ALT)
View More Recent Stories View Older Stories